Trial Profile
A trial of neoadjuvant chemoradiotherapy with Gimeracil/oteracil/tegafur in patients with borderline resectable pancreatic cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 06 Dec 2015 New trial record